At a share price of less than $4, this stock has the potential to deliver a big percentage gain if our thesis pans out. Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
Given this morning’s announcement, we are reevaluating our position in ARGS. Read More
I am closing out our position in Cardinal Health with a 15% increase over the past three months. Read More
You need to start thinking differently if you want to survive the next downturn. Since Donald Trump’s victory on Nov. 8, the stock market has signaled its approval by racking up a year’s worth of gains of 9.8% for the S&P 500. At the same time, its mid-cap cousin, the… Read More
You can still play big trends, if you know where to look. Read More
Our model tells us that this is a stock in transition that could easily see a big expansion in its earnings multiple once it turns positive. Read More
My guess is the same elements that worked in SNI’s favor during the third quarter – healthy growth in advertising sales and distribution revenues – will work against it this time. Read More
Gilead's weak quarterly report released after the close on Tuesday pushed its share price down 10% yesterday, closing beneath our stop price of $68. Read More
Cardinal soars, while Gilead and USANA head south Read More
We added Kohl’s (KSS) to our portfolio on Jan. 11 when it dropped 20% after it reported weak December sales and reduced full-year earnings guidance. Since then it has traded flat, establishing strong support just below our entry level price. That is likely to remain the case through Feb. 23,… Read More